AFX-5931

N/A

Report date: 2022/04/11 17:38:17
NME

Base Information

Drug NameAFX-5931
Drug Alias NameAFX-5931
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionC-C motif chemokine 2 modulatorsC-C motif chemokine 5 modulators
TargetsC-C motif chemokine 2C-C motif chemokine 5
Therapy Area/IndicationsEczema
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAfecta Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesAfecta Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsEczema
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A